Judy Sutherland
Impact in
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 10
- Genetics 4
- Chronic Lymphocytic Leukemia Research 4
- Co-authors
- Joseph M. ConnorsKaramjit GillLaurie H. SehnC. P. FitzgeraldRandy D. GascoyneRichard KlasaMukesh ChhanabhaiBrian Berry
- Journals
- Blood (5 papers)Journal of Clinical Oncology (1 paper)Diabetic Medicine (1 paper)Leukemia & lymphoma (4 papers)
- Partner nations
- CanadaIndiaUnited States
In The Last Decade
Judy Sutherland
11 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 73
- Pathology and Forensic Medicine 1.8k
- Genetics 628
- Oncology 1.1k
- Neurology 539
- Immunology 200
Countries citing papers authored by Judy Sutherland
This map shows the geographic impact of Judy Sutherland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judy Sutherland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judy Sutherland more than expected).
Fields of papers citing papers by Judy Sutherland
This network shows the impact of papers produced by Judy Sutherland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judy Sutherland. The network helps show where Judy Sutherland may publish in the future.
Co-authors
The 25 scholars most cited alongside Judy Sutherland, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 21 | |
| 2 | 2008 | 9 | |
| 3 | 2007 | 70 | |
| 4 | 2007 | 46 | |
| 5 | 2006 | 6 | |
| 6 | 2006 | 1 | |
| 7 | The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP Hit paper breakdown → | 2006 | 1033 |
| 8 | Introduction of Combined CHOP Plus Rituximab Therapy Dramatically Improved Outcome of Diffuse Large B-Cell Lymphoma in British Columbia Hit paper breakdown → | 2005 | 744 |
| 9 | 2005 | 10 | |
| 10 | 2004 | 12 | |
| 11 | 1986 | 15 |
About Judy Sutherland
Judy Sutherland is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Gastroenterology and Dermatology, having authored 11 papers that have together received 2.0k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (10 papers), Viral-associated cancers and disorders (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), Lung Cancer Treatments and Mutations (2 papers), Clinical practice guidelines implementation (1 paper), Diabetes, Cardiovascular Risks, and Lipoproteins (1 paper), Primary Care and Health Outcomes (1 paper) and Acute Lymphoblastic Leukemia research (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (1.8k citations), Genetics (628 citations), Oncology (1.1k citations), Neurology (539 citations) and Immunology (200 citations). Judy Sutherland has collaborated with scholars based in Canada, India and United States. Frequent co-authors include Joseph M. Connors, Karamjit Gill, Laurie H. Sehn, C. P. Fitzgerald, Randy D. Gascoyne, Richard Klasa, Mukesh Chhanabhai, Brian Berry, Tamara Shenkier and Kerry J. Savage. Their work appears in journals such as Blood, Journal of Clinical Oncology, Diabetic Medicine and Leukemia & lymphoma.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.